REG to conduct strategic review of REG Life Sciences activities

By Renewable Energy Group Inc. | November 21, 2016

Renewable Energy Group's board of directors recently authorized a review of strategic alternatives for its Life Sciences subsidiary, which is developing renewable chemicals and fuels using a proprietary microbial fermentation process. The strategic review process will be comprehensive and focused on the best path to maximize shareholder value.

Over the last three years under REG ownership, the Life Sciences subsidiary has advanced its technology, increased the number of potential products that can be made from the technology and expanded its intellectual property portfolio.

"REG Life Sciences recently announced its first commercial product," said Daniel J. Oh, REG's president and CEO. "We believe now is the right time to review strategic alternatives for Life Sciences in order to generate value from this investment. The REG board of directors and management are committed to delivering value for our shareholders, and today's announcement underscores our stated objective to optimize our portfolio."

There can be no assurance that the strategic review will result in any specific action or transaction. REG does not intend to provide updates concerning this strategic review process until its board of directors has approved a specific action or REG has otherwise determined that further disclosure is appropriate.